Why?

Heart failure (HF) is the top reason for global deaths and healthcare costs.

 

Current HF devices are risky (like catheters) or give unclear info (like wearables). This creates problems – wrong meds, longer hospital stays (about 4 days), and many people returning to the hospital within a month (23%). We need better solutions.

MedInnovate has come up with an innovative minimally invasive Bluetooth-connected device that monitors the vital parameters in Heart failure and mobilizes the ASHA Services in the Golden Period thereby reducing patient readmission and opportunistic cost of healthcare.

​

MedInnovate has the patient-first approach and is currently in the concept phase on the application of Near Infrared Spectroscopy (NIRS) in the detection of Cardiac Failure patients based on existing literature and studies that have been conducted on NIRS.